Mark Foletta
Förmögenhet: 5 M $ per 2026-10-31
Förmögenhet: 5 M $ per 2026-10-31
Mr. Mark G.
Foletta, CPA, is an Independent Director at Enanta Pharmaceuticals, Inc., a Lead Independent Director at DexCom, Inc., a Chairman at AMN Healthcare Services, Inc., a Member at Corporate Directors Forum and a Member at The Financial Executives Institute.
He is on the Board of Directors at Enanta Pharmaceuticals, Inc. and DexCom, Inc. Mr. Foletta was previously employed as a Chief Financial Officer & Executive Vice President by Tocagen, Inc., a Chief Financial Officer by Biocept, Inc., an Independent Director by Ambit Biosciences Corp., an Independent Director by Regulus Therapeutics, Inc., an Independent Director by Anadys Pharmaceuticals, Inc., a Chief Financial Officer & Senior VP-Finance by Amylin Pharmaceuticals, Inc., a Principal by Triton Group Management, Inc., an Audit Manager by Ernst & Young LLP, a Chief Financial Officer, Secretary & Senior VP by Intermark, Inc., and a Chief Financial Officer, Secretary & Senior VP by Triton Group Ltd. He also served on the board at ViaCyte, Inc. and Islet Sciences, Inc. He received his undergraduate degree from the University of California, Santa Barbara.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
DEXCOM, INC. 0,01 % | 2026-08-03 | 55 183 ( 0,01 % ) | 5 M $ | 2026-10-31 |
| 2026-06-15 | 17 917 ( 0,05 % ) | 844 070 $ | 2026-10-31 | |
| 2026-03-11 | 0 ( -.--% ) | - $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| AMN HEALTHCARE SERVICES, INC. | Ordförande | 2025-02-04 |
| DEXCOM, INC. | Direktör/Styrelseledamot | 2014-11-19 |
| ENANTA PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2020-06-29 |
The Financial Executives Institute | Företagsledare/Principal | - |
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Operates as corporate directors forum | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Direktör/Styrelseledamot | 2022-09-01 |
| FORTE BIOSCIENCES | Finansdirektör/CFO | 2020-06-15 |
| REGULUS THERAPEUTICS INC. | Direktör/Styrelseledamot | 2018-05-31 |
| BIOCEPT, INC. | Finansdirektör/CFO | 2016-07-27 |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 18 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
AMN Healthcare Services, Inc.
AMN Healthcare Services, Inc. Personnel ServicesCommercial Services Provides healthcare staffing and workforce optimization services | Commercial Services |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Biocept, Inc.
Biocept, Inc. Medical/Nursing ServicesHealth Services Develops and performs clinical laboratory tests to detection & analysis of tumor cells and cell-free DNA from cerebrospinal fluid | Health Services |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Ambit Biosciences Corp.
Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Tocagen, Inc.
Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
Intermark, Inc.
Intermark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business services | Commercial Services |
Triton Group Ltd.
Triton Group Ltd. Auto Parts: OEMProducer Manufacturing Distributes & repairs turbine engines | Producer Manufacturing |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
The Financial Executives Institute | |
Corporate Directors Forum
Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Operates as corporate directors forum | Commercial Services |
Triton Group Management, Inc. | |
Regulus Therapeutics, Inc.
Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Islet Sciences, Inc.
Islet Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops new medicines and technologies for the diagnosis and treatment of metabolic disease | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån